Ingredient, product, purpose
Is semaglutide the drug being offered?
Semaglutide (Ozempic, Wegovy) copies the effects of a hormone, a natural message from your gut. This message helps with feeling full and controlling blood sugar.
A shared ingredient can have different uses
Ask about
What the answer needs to cover
Semaglutide (Ozempic)
The September 2026 approval for Ozempic included blood-sugar management in adults who have type 2 diabetes. Adults who had both type 2 diabetes and heart disease were also covered by approval for reducing stroke and heart attack risk. For adults with long-term kidney disease as well as type 2 diabetes, approval also covered slowing kidney disease and reducing the risk of death related to the heart.
It was not approved for weight loss in September 2026.
Semaglutide (Wegovy)
The September 2026 approval for Wegovy covered losing weight and maintaining that loss.
Tablet or injection
The Ozempic and Wegovy names covered both tablets and shots in September 2026.
Ask for the full name and form. The ingredient alone does not settle the product’s approved use.
What “approved” means here
FDA approval is the US drug agency’s review of a product for named uses.
A prescriber can use an approved drug to treat a problem the FDA has not approved it for. US rules allowed this in September 2026.
If that is the plan, ask why it fits your case and how payment will work.
A generic is a copy approved to match a brand medicine.
As of September 2026, no generic semaglutide had final FDA approval for US marketing.
If an offer calls it a generic, ask for the approval record.
What a weight trial found
Trial detail
What it showed
STEP 1
For STEP 1 participants without diabetes, the 68-week weight-loss average reached 14.9% on semaglutide; on placebo it was 2.4%.
The placebo was a dummy shot without semaglutide.
The setting
The drug’s maker paid for the trial, which provided regular visits plus support for eating and activity.
These are trial averages for a group; each person’s result can differ.
What else needs a plan?
The Wegovy label lists nausea, vomiting, diarrhoea and constipation as common problems.
Nausea means feeling as if you may vomit.
The label tells prescribers to check pregnancy or surgery plans, eye damage from diabetes, serious stomach problems and cancer history involving the thyroid. The thyroid is a small body part found in your neck.
Bring any family cancer names you know; the safety card explains which thyroid cancer rules these medicines out.
Ask how the other problems affect your medicine choice or follow-up care.
Keep these questions open
- Why this form rather than another option?
- What would count as useful progress for me?
- When will we review whether the plan still fits?